Shivshivam Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 5.20 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.35 Cr
- Satisfied Charges ₹ 4.50 Cr
- Revenue Growth 122.42%
- Profit Growth 101.77%
- Ebitda 98.13%
- Net Worth 75.77%
- Total Assets 141.26%
About Shivshivam Pharma
Shivshivam Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2018 (Six years and ten months 21 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.20 M.
The company currently has active open charges totaling ₹14.35 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradip Mohta and Lakshya Mohta serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999WB2018PTC225241
-
Company No.
225241
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Mar 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Shivshivam Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradip Mohta
|
Director | 20-Mar-2018 | Current |
|
Lakshya Mohta
|
Director | 20-Mar-2018 | Current |
Financial Performance of Shivshivam Pharma.
Shivshivam Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 122.42% increase. The company also saw a substantial improvement in profitability, with a 101.77% increase in profit. The company's net worth Soared by an impressive increase of 75.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shivshivam Pharma?
Unlock access to Shivshivam Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vikash Biotec Private LimitedPradip Mohta is a mutual person
-
Think Box Solutions Private Limited
Pradip Mohta is a mutual person
Charges (Loans)
₹143.50 M
₹45.00 M
Charges Breakdown by Lending Institutions
- Others : 14.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2024 | Others | ₹14.35 Cr | Open |
| 25 Oct 2021 | Others | ₹4.50 Cr | Satisfied |
How Many Employees Work at Shivshivam Pharma?
Unlock and access historical data on people associated with Shivshivam Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shivshivam Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivshivam Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
